MedTrace Logo

Inflammatory Biomarkers of Pediatric Pulmonary Hypertension

NCT03581695 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2026-05-04

No results posted yet for this study

Summary

To investigate if the inflammatory protein, high mobility group box 1 (HMGB1), along with other inflammatory mediators, is elevated in pediatric patients with congenital heart disease (CHD) and pulmonary hypertension as compared to those with CHD alone, or with healthy controls.

Conditions

  • Hypertension, Pulmonary

Interventions

OTHER

Blood test

Blood test

Sponsors & Collaborators

  • The Hospital for Sick Children

    lead OTHER

Principal Investigators

  • Katherine Taylor · The Hospital for Sick Children

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-20
Primary Completion
2022-05-11
Completion
2024-07-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03581695 on ClinicalTrials.gov